Geode Capital Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Geode Capital Management’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.5K	Buy	19,941 +4,033	+25%	+$11.8K	﹤0.01%	4350
2025 Q4	$57.9K	Sell	15,908 -1,709	-10%	-$6.3K	﹤0.01%	4208
2025 Q3	$68.4K	Hold	17,617	–	–	﹤0.01%	4221
2025 Q2	$50.6K	Buy	17,617 +812	+5%	+$2.45K	﹤0.01%	4215
2025 Q1	$36.8K	Buy	+16,805	New	+$45.5K	﹤0.01%	4248
2024 Q3	–	Sell	-4,332	Closed	-$18.4K	–	4577
2024 Q2	$18.4K	Buy	4,332 +2,543	+142%	+$9.04K	﹤0.01%	4467
2024 Q1	$5.95K	Hold	1,789	–	–	﹤0.01%	4580
2023 Q4	$6.45K	Hold	1,789	–	–	﹤0.01%	4620
2023 Q3	$27.6K	Sell	1,789 -22	-1%	-$430	﹤0.01%	4558
2023 Q2	$39.5K	Hold	1,811	–	–	﹤0.01%	4559
2023 Q1	$35.4K	Sell	1,811 -27	-1%	-$696	﹤0.01%	4594
2022 Q4	$41K	Sell	1,838 -6	-0.3%	-$214	﹤0.01%	4647
2022 Q3	$78K	Hold	1,844	–	–	﹤0.01%	4662
2022 Q2	$108K	Hold	1,844	–	–	﹤0.01%	4562
2022 Q1	$147K	Hold	1,844	–	–	﹤0.01%	4515
2021 Q4	$168K	Hold	1,844	–	–	﹤0.01%	4559
2021 Q3	$205K	Buy	1,844 +335	+22%	+$41.2K	﹤0.01%	4439
2021 Q2	$221K	Buy	+1,509	New	+$237K	﹤0.01%	4308
2019 Q2	–	Sell	-73	Closed	-$12K	–	4236
2019 Q1	$12K	Hold	73	–	–	﹤0.01%	4116
2018 Q4	$9K	Hold	73	–	–	﹤0.01%	4129
2018 Q3	$19K	Hold	73	–	–	﹤0.01%	4096
2018 Q2	$32K	Hold	73	–	–	﹤0.01%	4009
2018 Q1	$48K	Hold	73	–	–	﹤0.01%	3954
2017 Q4	$72K	Hold	73	–	–	﹤0.01%	3877
2017 Q3	$68K	Hold	73	–	–	﹤0.01%	3888
2017 Q2	$87K	Sell	73 -10	-12%	-$12.3K	﹤0.01%	3869
2017 Q1	$107K	Buy	83 +8	+11%	+$9.3K	﹤0.01%	3817
2016 Q4	$67K	Hold	75	–	–	﹤0.01%	3865
2016 Q3	$58K	Hold	75	–	–	﹤0.01%	3897
2016 Q2	$53K	Hold	75	–	–	﹤0.01%	3916
2016 Q1	$64	Hold	75	–	–	﹤0.01%	3928
2015 Q4	$77K	Hold	75	–	–	﹤0.01%	3938
2015 Q3	$86K	Buy	75 +47	+168%	+$55.7K	﹤0.01%	3930
2015 Q2	$35K	Buy	28 +1	+4%	+$937	﹤0.01%	3900
2015 Q1	$20K	Hold	27	–	–	﹤0.01%	3920
2014 Q4	$35K	Hold	27	–	–	﹤0.01%	3917
2014 Q3	$57K	Buy	27 +6	+29%	+$14K	﹤0.01%	3823
2014 Q2	$59K	Hold	21	–	–	﹤0.01%	3761
2014 Q1	$72K	Buy	+21	New	+$71.4K	﹤0.01%	3720

Other funds holding SNOA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Geode Capital Management's SNOA Position: Q1 2026 in Review

Geode Capital Management increased its Sonoma Pharmaceuticals (SNOA) stake by 25% in Q1 2026, buying an estimated $11.8K and bringing the position to 19,941 shares worth $42.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4350.

Geode Capital Management first reported a position in SNOA in Q1 2014 and has held it in 39 quarters since. The position peaked at $221K in Q2 2021. 17 funds tracked by Wall St. Rank hold SNOA as of Q1 2026.

Geode Capital Management held 19,941 shares of Sonoma Pharmaceuticals worth $42.5K as of Q1 2026.
Geode Capital Management bought 4,033 Sonoma Pharmaceuticals shares in Q1 2026, an estimated $11.8K.
Sonoma Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4350 holding.
Geode Capital Management first reported a position in Sonoma Pharmaceuticals in Q1 2014 and has held it in 39 quarters since.
Geode Capital Management's Sonoma Pharmaceuticals position peaked at $221K in Q2 2021.
17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.